Skip header and navigation

Narrow By

   MORE

30 records – page 1 of 2.

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1138
Available Online
View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Crohn's disease
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Crohn's disease
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Ulcerative proctitis

https://libcat.nshealth.ca/en/permalink/chpams35311
Nova Scotia Health Authority. GI Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1422
Available Online
View Pamphlet
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. GI Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Colitis, Ulcerative
Inflammatory Bowel Diseases
Subjects (LCSH)
Ulcerative colitis
Inflammatory bowel diseases
Abstract
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Responsibility
Prepared by: GI Clinic
Pamphlet Number
1422
Less detail

Corticosteroid therapy in inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1546
Available Online
View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Corticosteroid therapy in IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Subjects (LCSH)
Inflammatory bowel diseases
Prednisone
Specialty
Gastrointestinal System
Medications
Abstract
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Notes
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1546
Less detail

Inflammatory Bowel Disease Nursing Manual

https://libcat.nshealth.ca/en/permalink/provcat44092
Andreas Sturm, Lydia White, editors. --Cham: Springer , 2019.
Available Online
View e-Book
Location
Online
This comprehensive manual discusses the many aspects of inflammatory bowel disease (IBD), providing relevant information along with practical guidance. The reader is also directed to additional resources for extra and current information. This book comes at a time when the number of people suffering from the two major forms of IBD, ulcerative colitis (UC) and Crohn’s disease (CD), is rising around the globe. Despite their huge impact on daily life and health economics, these diseases are not fu…
Available Online
View e-Book
Other Authors
Sturm, Andreas
White, Lydia
Responsibility
Andreas Sturm, Lydia White, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2019
Physical Description
1 online resource (xvi, 495 p.) : 81 illus., 59 illus. in color
ISBN
9783319750224
9783319750217 (Print ed.)
9783319750231 (Print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases - nursing
Specialty
Gastroenterology
Nursing
Abstract
This comprehensive manual discusses the many aspects of inflammatory bowel disease (IBD), providing relevant information along with practical guidance. The reader is also directed to additional resources for extra and current information. This book comes at a time when the number of people suffering from the two major forms of IBD, ulcerative colitis (UC) and Crohn’s disease (CD), is rising around the globe. Despite their huge impact on daily life and health economics, these diseases are not fully understood, and diagnosis and treatment remains a significant challenge. IBD nurses are increasingly recognised as key clinicians within the multidisciplinary team caring for people with IBD. Through experience and specialist knowledge IBD nurses provide timely support, advice, and treatment for people living with this unpredictable condition. IBD nurses are also well placed to liaise with the wider team, developing patient centred services which best fit their local health framework. The combined international expertise and accessible guidance here will equip nurses, or any clinician wanting to increase their competence in IBD management. Thereby this manual aims to contribute to the optimisation of IBD care throughout the world.
Contents
Part I. IBD Foundations: Anatomy and Physiology -- Epidemiology -- Aetiology, Pathophysiology and Localisation -- Part II. Diagnosis, Assessment and Monitoring: Clinical Assessment -- Endoscopy -- Lab -- Radiology -- Histopathology -- Monitoring -- Differential Diagnosis -- Part III. Managing IBD -- Medical Management 1: General -- Medical Management 2: Conventional -- Medical Management 3: Biological -- New Therapeutic Treatments -- Antibiotics and Microflora (FMP) -- Risks and Side-Effects of Medical Therapy -- Surgical Management -- Short Bowel Syndrome -- Alternative Therapies -- Part IV. Complications and Comorbidities: EIMs -- Penetrating CD and Fistulae -- Opportunistic Infections -- Cancer -- Part V. The Patient in... -- Newly Diagnosed Patient -- Fertility, Pregnancy and Lactation -- Young IBD -- Elderly -- Patient Priorities -- Dietary Management -- Stoma -- Pouch Care -- Adherence -- Constipation -- Part VI. Lifestyle Issues: Travel and Vaccination -- Smoking and Drugs -- Stress and Psychological Support -- Communication Skills -- Sport -- Sex and Intimacy -- Patient Support Groups -- Part VII. Research: Clinical Studies -- Nursing Research -- Part VIII. IBD Nursing: Training and Education -- E-health -- In Patient Care -- Nursing Support and IBD Networking -- Advice Lines -- Clinics -- Maintaining and IBD Nurse Service -- IBD Nurse Within the MDT.
Format
e-Book
Location
Online
Less detail

Cancer Screening in Inflammatory Bowel Disease : A Guide to Risk Management and Techniques

https://libcat.nshealth.ca/en/permalink/provcat44388
Joseph D. Feuerstein, Adam S. Cheifetz, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging dru…
Available Online
View e-Book
Other Authors
Feuerstein, Joseph D.
Cheifetz, Adam S.
Responsibility
Joseph D. Feuerstein, Adam S. Cheifetz, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xi, 174 p.) : 14 illus. in color
ISBN
9783030153014
9783030153007 (Print ed.)
9783030153021 (Print ed.)
9783030153038 (Print ed.)
Subjects (MeSH)
Colorectal Neoplasms - diagnosis
Inflammatory Bowel Diseases - complications
Risk Factors
Specialty
Gastroenterology
Medical Oncology
Abstract
This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.
Contents
Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.
Format
e-Book
Location
Online
Less detail

Mastery of IBD Surgery

https://libcat.nshealth.ca/en/permalink/provcat44458
Neil Hyman, Phillip Fleshner, Scott Strong, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book provides a guide to the management of patients with Crohn’s disease and ulcerative colitis. The indications for surgery within inflammatory bowel disease are covered, as well as new biologic medications and the effects they have on the immune system. Details on how these drugs should be managed to avoid complications and ensure patient safety are also included. Mastery of IBD Surgery sets out to cover surgical responses to inflammatory bowel disease from a multidisciplinary perspectiv…
Available Online
View e-Book
Other Authors
Hyman, Neil
Fleshner, Phillip
Strong, Scott
Responsibility
Neil Hyman, Phillip Fleshner, Scott Strong, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xi, 409 p.) : 8 illus. in color
ISBN
9783030167554
9783030167547 (Print ed.)
9783030167561 (Print ed.)
9783030167578 (Print ed.)
Subjects (MeSH)
Colitis, Ulcerative - surgery
Crohn Disease - surgery
Inflammatory Bowel Diseases - therapy
Specialty
Colorectal Surgery
Abstract
This book provides a guide to the management of patients with Crohn’s disease and ulcerative colitis. The indications for surgery within inflammatory bowel disease are covered, as well as new biologic medications and the effects they have on the immune system. Details on how these drugs should be managed to avoid complications and ensure patient safety are also included. Mastery of IBD Surgery sets out to cover surgical responses to inflammatory bowel disease from a multidisciplinary perspective and aims to help all surgeons and medical professionals working in this area. This book is relevant to colorectal surgeons, gastrointestinal surgeons, and gastroenterologists.
Contents
Nutritional Repletion in the Surgical Patient -- Preoperative Bowel Prep -- Extended Venous Thromboembolism Prophylaxis after Surgery for Inflammatory Bowel Diseases -- The Use of Enhanced Recovery Pathways in Patients Undergoing Surgery for Inflammatory Bowel Disease -- Perioperative Steroid Management in IBD Patients Undergoing Colorectal Surgery -- Managing Immunomodulators Perioperatively -- Managing Biologics Perioperatively -- Management of Perianal Skin Tags -- Management of Chronic Anal Fissures in Patients with Crohn’s Disease -- Management of Simple Anoperineal Fistulas -- Management of Severe Anoperineal Disease -- Management of Ano/Rectovaginal Fistula -- Proctectomy in Patients with “Watering Can” Perineum -- Management of Isolated Proctitis/Proctosigmoiditis -- Role of IPAA for Crohn’s Disease -- Surgical Options for Neoplasia Complicating Crohn’s Disease of the Large Intestine -- The Role of Segmental Resection for Colon Disease -- Role of Percutaneous Drainage for Disease-Related Abscesses -- Management After Successful Percutaneous Drainage of Disease-Related Abscess -- Intraoperative Detection of Upper Gastrointestinal Strictures -- Management of Long Segment Small Bowel Crohn’s Disease -- Construction of the Ideal Ileocolic Anastomosis in Crohn’s Disease -- Management of Enteroenteric Fistula -- Preventing Postoperative Crohn’s Disease Recurrence -- Role of Minimally Invasive Reoperative Surgery -- Extent of Mesenteric Resection -- Role of Endoscopic Management in Ulcerative Colitis Patients with Dysplasia -- Surgical Options for Endoscopically Unresectable Dysplasia in Ulcerative Colitis -- Management of Ulcerative Colitis in Patients with Rectal Cancer -- Surgical Approach to the Older Ulcerative Colitis Patient -- Role of Minimally Invasive Surgery in Pouch Surgery -- How Many Stages Should We Use in Pouch Surgery? -- Optimal Design for Ileal-Pouch Anal Anastomosis -- Failed Pouch-Pouch Excision vs Redo -- Mucosectomy Versus Stapled Ileal Pouch-Anal Anastomosis -- Transanal Proctectomy and Ileoanal Pouch Procedure (ta-J Pouch) -- Use of Antiadhesive Barriers in Pouch Surgery -- Optimal Management of Pelvic Abscess after Pouch Surgery -- Management of Chronic Pouchitis -- Management of Ileal Pouch Vaginal Fistulas -- Management of IPAA-Associated Persistent Presacral Sinus -- The Management of Patients with Dysplasia in the Anal Transitional Zone -- Pouch Excision Versus Diversion for the Failed Pouch -- Pouch Excision vs. Redo IPAA After a Failed Pouch -- Continent Ileostomy after Removal of a Failed IPAA.
Format
e-Book
Location
Online
Less detail

Biomarkers in Inflammatory Bowel Diseases

https://libcat.nshealth.ca/en/permalink/provcat44481
Nik Sheng Ding, Peter De Cruz, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, p…
Available Online
View e-Book
Other Authors
Sheng Ding, Nik
De Cruz, Peter
Responsibility
Nik Sheng Ding, Peter De Cruz, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xvii, 365 p.) : 35 illus., 30 illus. in color
ISBN
9783030114466
9783030114459 (Print ed.)
9783030114473 (Print ed.)
Subjects (MeSH)
Biomarkers
Inflammatory Bowel Diseases - diagnosis
Specialty
Clinical Laboratory Techniques
Gastroenterology
Abstract
This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
Contents
1. Introduction -- Part I. Background to Biomarkers -- 2. Clinical Risk Factors: Lessons from Epidemiology -- 3. Disease Modification in Crohn’s Disease -- 4. Personalized Medicine - Dream or Reality? -- 5. Clinical Trial Design to Facilitate Biomarker Discovery -- Part II. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Crohn’s Disease -- 6. Luminal Crohn’s Disease -- 7. Fibrosis and Stricturing Disease in Crohn’s Disease -- 8. Postoperative Crohn’s Disease -- 9. Perianal Crohn’s Disease -- Part III. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Ulcerative Colitis -- 10. Biomarkers in Acute Severe Ulcerative Colitis -- 11. Chronic Active Ulcerative Colitis -- 12. Refractory Proctitis -- 13. UC Surveillance -- 14. The Role of Biomarkers in the Ileal Anal Pouch -- Part IV. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Specialised Scenarios -- 15. Extra-intestinal Manifestations in Inflammatory Bowel Disease: Diagnosis and Management -- 16. Primary Sclerosing Cholangitis Overlapping with IBD -- 17. Pregnancy and IBD -- 18. Nutrition in IBD -- 19. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Optimising Therapeutic Effectiveness of Thiopurines -- 20. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Optimising Therapeutic Effectiveness of Biologics -- 21. Drug Toxicity: Personalising IBD Therapeutics–The Use of Genetic Biomarkers to Reduce Drug Toxicity -- 22. Biomarkers for Remote Monitoring -- Part V. Scientific Platforms for Biomarker Discovery -- 23. Exposome and Diet -- 24. The Microbiome in IBD -- 25. Metabolic Profiling in IBD -- 26. Innate and Adaptive Immunology -- 27. Genetic and Genomic Markers for Prognostication -- 28. Risk Alleles for Drug Targets: Genomic Markers of Drug Response -- Part VI. Conclusion -- 29. Big Data Meets Real World! The Use of Clinical Informatics in Biomarker Research -- 30. Bringing It Altogether: A Systems Biology Approach to Biomarkers in Inflammatory Bowel Disease.
Format
e-Book
Location
Online
Less detail

Interventional inflammatory bowel diseases : endoscopic management and treatment of complications

https://libcat.nshealth.ca/en/permalink/provcat42077
edited by Bo Shen. (1st ed.) --London, UK: Elsevier , c2018.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Interventional Inflammatory Bowel Diseases: Endoscopic Management and Treatment of Complications covers the preparation, principle, techniques, and damage control of complications in endoscopic therapy providing the ultimate guidance in endoscopic management of IBD. With contributions from a panel of international leading experts in the field, perspectives are included from GI pathologists, GI radiologists, gastroenterologists, advanced endoscopists, IBD specialists, and colorectal surgeons.
Available Online
View e-Book
Other Authors
Shen, Bo
Responsibility
edited by Bo Shen
Edition
1st ed.
Alternate Title
Atlas of surgical techniques for the upper GI tract and small bowel
Place of Publication
London, UK
Publisher
Elsevier
Date of Publication
c2018
Physical Description
1 online resource, 352 p.
ISBN
9780128113882
Subjects (MeSH)
Inflammatory Bowel Diseases
Specialty
Endoscopy
Gastroenterology
Abstract
Interventional Inflammatory Bowel Diseases: Endoscopic Management and Treatment of Complications covers the preparation, principle, techniques, and damage control of complications in endoscopic therapy providing the ultimate guidance in endoscopic management of IBD. With contributions from a panel of international leading experts in the field, perspectives are included from GI pathologists, GI radiologists, gastroenterologists, advanced endoscopists, IBD specialists, and colorectal surgeons.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Endoscopy in Pediatric Inflammatory Bowel Disease

https://libcat.nshealth.ca/en/permalink/provcat42825
Luigi Dall'Oglio, Claudio Romano, editors. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book describes an up-to-date practical strategy for the use of endoscopy in the evaluation and management of pediatric patients with inflammatory bowel disease (IBD). All aspects of the role of endoscopy in Crohn's disease (CD) and ulcerative colitis (UC)—the two most common types of IBD—are addressed. Readers will find detailed information on its use in the initial diagnosis of IBD, differentiation between CD and UC, assessment of disease extent and activity, monitoring of response to the…
Available Online
View e-Book
Other Authors
Dall'Oglio, Luigi
Romano, Claudio
Responsibility
Luigi Dall'Oglio, Claudio Romano, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (ix, 103 p.) : 11 illus. in color
ISBN
9783319612492
9783319612485 (print ed.)
9783319612508 (print ed.)
Subjects (MeSH)
Child
Endoscopy - methods
Inflammatory Bowel Diseases - diagnostic imaging
Specialty
Endoscopy
Gastroenterology
Pediatrics
Abstract
This book describes an up-to-date practical strategy for the use of endoscopy in the evaluation and management of pediatric patients with inflammatory bowel disease (IBD). All aspects of the role of endoscopy in Crohn's disease (CD) and ulcerative colitis (UC)—the two most common types of IBD—are addressed. Readers will find detailed information on its use in the initial diagnosis of IBD, differentiation between CD and UC, assessment of disease extent and activity, monitoring of response to therapy, and surveillance for cancer and dysplasia. Attention is drawn to specific clinical and endoscopic features of CD and UC in the pediatric age group that serve to illustrate why the child is not to be regarded merely as a small adult. Helpful information is also supplied on equipment, patient and parent preparation, and sedation. Endoscopy is considered the best means of obtaining a definite diagnosis in children who may have IBD, and this book will be of value to practitioners at all levels of experience.
Contents
1. Equipment in Pediatric Endoscopy -- 2. Bowel Preparation and Factors Correlated with Patients and Parents -- 3. Sedation -- 4. Early Onset IBD: Endoscopic Features -- 5. Esophagogastroduodenoscopy and Ileocolonoscopy -- 6. Endoscopic Score in CD and UC -- 7. Small-Bowel Endoscopy -- 8. Operative Endoscopy in Pediatric Inflammatory Bowel Disease -- 9. Cancer and Dysplasia Surveillance -- 10. Conclusions.
Format
e-Book
Location
Online
Less detail

Treatment of Inflammatory Bowel Disease with Biologics

https://libcat.nshealth.ca/en/permalink/provcat42935
edited by Adam S. Cheifetz, Joseph D. Feuerstein. --Cham, Switzerland: Springer , c2018.
Available Online
View e-Book
Location
Online
This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment …
Available Online
View e-Book
Other Authors
Cheifetz, Adam S.
Feuerstein, Joseph D.
Responsibility
edited by Adam S. Cheifetz, Joseph D. Feuerstein
Place of Publication
Cham, Switzerland
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xi, 335 p.) : 22 illus., 19 illus. in color
ISBN
9783319602769
9783319602752 (print ed.)
9783319602776 (print ed.)
9783319868233 (print ed.)
Subjects (MeSH)
Anti-Inflammatory Agents - therapeutic use
Biological Products - therapeutic use
Inflammatory Bowel Diseases - drug therapy
Specialty
Biological Therapy
Gastroenterology
Abstract
This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
Contents
Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn's Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn's Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics—Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies.
Format
e-Book
Location
Online
Less detail

Advances in Endoscopy in Inflammatory Bowel Disease

https://libcat.nshealth.ca/en/permalink/provcat43311
Toshifumi Hibi, Tadakazu Hisamatsu, Taku Kobayashi, editors. --Tokyo: Springer , c2018.
Available Online
View e-Book
Location
Online
Advances in Endoscopy in Inflammatory Bowel Disease summarizes the recent progress made in endoscopy, an essential tool for the diagnosis and management of IBD. It goes on to provide an introduction of state-of-the-art endoscopic techniques, as well as an atlas of high-quality endoscopic images of IBD and related diseases. Among others, endoscopy is one of the clinical fields in which Asian countries are leading the way in the management of gastrointestinal disorders. As the number of patients …
Available Online
View e-Book
Other Authors
Hibi, Toshifumi
Hisamatsu, Tadakazu
Kobayashi, Taku
Responsibility
Toshifumi Hibi, Tadakazu Hisamatsu, Taku Kobayashi, editors
Alternate Title
Endoscopy in IBD
Place of Publication
Tokyo
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (ix, 282 p.) : 110 illus., 102 illus. in color
ISBN
9784431560180
9784431560166 (print ed.)
9784431560173 (print ed.)
9784431567547 (print ed.)
Subjects (MeSH)
Endoscopy, Gastrointestinal
Inflammatory Bowel Diseases - diagnostic imaging
Specialty
Endoscopy
Gastroenterology
Abstract
Advances in Endoscopy in Inflammatory Bowel Disease summarizes the recent progress made in endoscopy, an essential tool for the diagnosis and management of IBD. It goes on to provide an introduction of state-of-the-art endoscopic techniques, as well as an atlas of high-quality endoscopic images of IBD and related diseases. Among others, endoscopy is one of the clinical fields in which Asian countries are leading the way in the management of gastrointestinal disorders. As the number of patients with IBD is dramatically increasing in Asia, quality of patient care has been significantly improved. With diagnosis of intestinal Behcet, simple ulcers, and intestinal tuberculosis, which are unique to the Asian countries, this book offers the ideal standard textbook for IBD endoscopy in all Asian counties, while the superior quality of images also makes it a valuable resource for practitioners around the globe. This book will significantly help all physicians, endoscopists and researchers working on GI endoscopy, especially those focusing on IBD, to improve their knowledge of IBD endoscopy.
Contents
Part I. The role of endoscopy in IBD -- 1. The Role of Endoscopy in IBD -- 2. Current progress of endoscopy in IBD: Colonoscopy -- 3. Current progress of endoscopy in IBD: Balloon enteroscopy -- 4. Current progress of endoscopy in IBD: Capsule endoscopy -- 5. Current progress of endoscopy in IBD: CT enterography and CT colonography in IBD -- 6. Current progress of endoscopy in IBD: MR Enterography -- Part II. Endoscopic diagnosis of IBD -- 7. Diagnosis of UC-typical findings and diagnostic criteria -- 8. Typical Endoscopic Findings and Diagnostic Criteria for Crohn's Disease -- 9. Differential diagnosis of IBD: Endoscopic findings and diagnosis of intestinal Behçet’s disease and simple ulcer syndrome -- 10. Differential diagnosis of Inflammatory Bowel Disease: Endoscopic findings and diagnosis of intestinal tuberculosis -- 11. Endoscopic findings and diagnosis of other inflammatory bowel diseases of lower GI tract -- 12. Endoscopic findings and Diagnosis of other inflammatory diseases of lower GI tract (except for infectious): vascular, eosinophilic, inflammation associated with other diseases etc -- 13. Endoscopic findings and Diagnosis of infectious diseases of lower GI tract: bacterial, pseudomembraneous, amoebic colitis CMV -- 14. Difficulty in diagnosing IBD: a case study -- Part III. Endoscopy in the management of IBD -- 15. Endoscopy in the Management of Inflammatory Bowel Disease: Who, When, and How -- 16. Endoscopic index in UC -- 17. Endoscopic score in Crohn's disease -- 18. Mucosal healing in UC -- 19. The efficacies and issues for endoscopic assessment of mucosal healing in patients with Crohn's disease -- 20. Endoscopic intervention in IBD -- 21. Surveillance colonoscopy -- 22. Surveillance colonoscopy (Cases of small intestinal cancers in CD, Cases of anal cancers in CD) -- Part IV.: Endoscopy in IBD- international differences -- 23. Endoscopy in Inflammatory Bowel Disease: Asian perspectives with respect to Japan -- 24. Endoscopy in IBD: Asian Perspective: Korea -- 25. Endoscopy in Chinese IBD patients: similarities and differences to the Western world -- 26. Endoscopy in IBD: A South Asian perspective from India -- 27. Endoscopy in IBD: Asian Perspective: Singapore -- 28. Endoscopy in IBD: Western perspectives: North America -- 29. Endoscopy in IBD: Western Perspective: Europe.
Format
e-Book
Location
Online
Less detail

Introduction to Gastrointestinal Diseases. Vol. 1

https://libcat.nshealth.ca/en/permalink/provcat41611
Jakub Fichna, editor. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
Learn the basics and more of gastrointestinal diseases. Functional GI disorders and inflammatory bowel diseases have become a major medical, social and economic burden worldwide. The larger the number of patients suffering from irritable bowel syndrome or inflammatory bowel diseases, the greater the need to properly diagnose and cure. This book is a comprehensive guide through GI diseases, which can be used by practitioners and patients. It will allow: to explore the mechanisms underlying GI di…
Available Online
View e-Book
Other Authors
Fichna, Jakub
Responsibility
Jakub Fichna, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xii, 139 pages) : 9 illus.
ISBN
9783319490168
9783319490151 (print ed.)
Subjects (MeSH)
Gastrointestinal Diseases
Inflammatory Bowel Diseases - therapy
Irritable Bowel Syndrome - therapy
Abstract
Learn the basics and more of gastrointestinal diseases. Functional GI disorders and inflammatory bowel diseases have become a major medical, social and economic burden worldwide. The larger the number of patients suffering from irritable bowel syndrome or inflammatory bowel diseases, the greater the need to properly diagnose and cure. This book is a comprehensive guide through GI diseases, which can be used by practitioners and patients. It will allow: to explore the mechanisms underlying GI diseases; to accurately diagnose and find the best treatment; to learn how to alleviate GI disease symptoms by changing diet and lifestyle. This guide has been written by experts in the field who understand the needs of doctors and their patients. With this book, you will make sure that the GI disease can be properly managed.
Contents
Part I.. Irritable Bowel Syndrome and Functional Gastrointestinal Diseases -- 1. Current Theories for Development of Irritable Bowel Syndrome .2. Clinical Features of Irritable Bowel Syndrome -- 3. Irritable Bowel Syndrome: Diagnosis -- 4. Pharmacological and Clinical Treatment of Irritable Bowel Syndrome -- 5. IBS Patient’s Guide -- Part II. Inflammatory Bowel Disease -- 6. Pathogenesis of IBD -- 7. Clinical Features -- 8. Diagnostic Criteria in IBD (with Comments) -- 9. Clinical Treatment in IBD -- 10. IBD Patient’s Guide.
Format
e-Book
Location
Online
Less detail

Pediatric Inflammatory Bowel Disease

https://libcat.nshealth.ca/en/permalink/provcat41617
Petar Mamula, Andrew B. Grossman, Robert N. Baldassano, Judith R. Kelsen, Jonathan E. Markowitz, editors. (Third edition) --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
The latest edition of this essential text provides a comprehensive overview of the unique pediatric issues of inflammatory bowel disease. Through new and thoroughly revised chapters, the volume features updates regarding pathogenesis, clinic features, and management, with an emphasis on recent understanding of pharmacokinetics and the utilization of cutting edge therapeutic monitoring to maximize efficacy of medical management. The new edition also highlights newer, recently approved drugs, eme…
Available Online
View e-Book
Other Authors
Mamula, Petar
Grossman, Andrew B
Baldassano, Robert N
Kelsen, Judith R
Markowitz, Jonathan E
Responsibility
Petar Mamula, Andrew B. Grossman, Robert N. Baldassano, Judith R. Kelsen, Jonathan E. Markowitz, editors
Edition
Third edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xxi, 754 pages) : 147 illus., 99 illus. in color
ISBN
9783319492155
9783319492131 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases - diagnosis
Inflammatory Bowel Diseases - therapy
Abstract
The latest edition of this essential text provides a comprehensive overview of the unique pediatric issues of inflammatory bowel disease. Through new and thoroughly revised chapters, the volume features updates regarding pathogenesis, clinic features, and management, with an emphasis on recent understanding of pharmacokinetics and the utilization of cutting edge therapeutic monitoring to maximize efficacy of medical management. The new edition also highlights newer, recently approved drugs, emerging therapies, and the most recent recommendations regarding post-operative management for patients who ultimately require surgery. Written by experts in the field, Pediatric Inflammatory Bowel Disease, Third Edition is a valuable resource for both pediatric and adult gastroenterologists involved in the care of children with inflammatory bowel disease.
Contents
Part I: Etiology and Pathogenesis -- Genetics of Inflammatory Bowel Diseases -- The Intestinal Immune System During Homeostasis and Inflammatory Bowel Disease -- Cytokines and Inflammatory Bowel Disease -- The Gut Microbiota and Inflammatory Bowel Disease -- Immune Dysregulation Associated with Very Early-Onset Inflammatory Bowel Disease -- Part II: Epidemiology and Clinical Features-- Epidemiology of Pediatric Inflammatory Bowel Disease -- The Natural History of Crohn Disease in Children -- Natural History of Ulcerative Colitis in Children -- Natural History of Pediatric Indeterminate Colitis -- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease -- Liver Disease in Pediatric Inflammatory Bowel Disease -- Growth Impairment in Pediatric Inflammatory Bowel Disease -- Inflammatory Bowel Diseases and Skeletal Health -- Puberty and Pediatric-Onset Inflammatory Bowel Disease -- Classification of Inflammatory Bowel Disease in Children -- Part III: Diagnosis -- The History and Physical Exam -- Differential Diagnosis of Inflammatory Bowel Disease -- Laboratory Evaulation of Inflammatory Bowel Disease -- Fecal Biomarkers in Inflammatory Bowel Disease -- Radiologic Evaulation of Pediatric Inflammatory Bowel Disease -- Endoscopy and Inflammatory Bowel Disease -- The Pathology of Chronic Inflammatory Bowel Disease -- Video Capsule Endoscopy in Inflammatory Bowel Disease -- Bone Health in Pediatric Inflammatory Bowel Disease -- Part IV: Medical Therapy -- 5-Aminosalicylate Therapy -- Antibiotic Therapy -- Nutritional Management of Inflammatory Bowel Disease -- Probiotic Therapy -- Corticosteroids -- 6-Mercaptopurpine Therapy -- Methotrexate -- Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis -- Anti-TNF Biologic Therapies Other Than Infliximab -- Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease -- New Non-anti-TNF Therapies for the Treatment of Inflammatory Bowel Disease -- Medical Treatment of Perianal Crohn's Disease Fistulae -- Treatment of Acute Severe Ulcerative Colitis -- Dietary Therapies for Inflammatory Bowel Disease -- Complementary and Alternative Therapies -- Part V: Surgical Considerations -- Management of Intraabdominal Complications of Inflammatory Bowel Disease -- Surgical Management of Crohn Disease in Children -- Surgical Treatment of Ulcerative Colitis -- Postoperative Surveillance and Management of Crohn's Disease -- Pouchitis After Ileal Pouch-Anal Anastomosis -- Enteral Feeding Devices and Ostomies -- Part VI: Research -- Clinical Indices for Pediatric Inflammatory Bowel Disease Research -- Clinical Trials (Clinical Perspective) -- Clinical Trials (Industry/Regulatory Perspective) -- Part VII: Special Considerations -- Infectious Complications of Pediatric Inflammatory Bowel Disease -- Psychological Aspects of Inflammatory Bowel Disease in Children and Adolescents -- Measurement of Quality of Life in Pediatric Inflammatory BOwel Disease -- Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease -- Inflammatory Bowel Disease in Pregnancy -- Immunizations in the Child with Inflammatory Bowel Disease -- Malignant Tumors Arising in Inflammatory Bowel Disease -- Quality Improvement in Inflammatory Bowel Disease -- Fostering Self-Management and Patient Activation -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Legislative Advocacy -- Transition from Pediatric to Adult Care.
Format
e-Book
Location
Online
Less detail

Inflammatory Bowel Disease : Diagnosis and Therapeutics

https://libcat.nshealth.ca/en/permalink/provcat41732
Russell D. Cohen, editor. (Third edition) --Cham: Humana Press , 2017.
Available Online
View e-Book
Location
Online
The latest edition of this text provides a comprehensive overview of the "natural flow of knowledge" regarding inflammatory bowel disease, with an emphasis on state-of-the art approaches that should be the basis for diagnosis and treatment of most patients. In addition to updated chapters, this volume includes new chapters on such topics as the impending biosimilar revolution, quality of care, and new challenges to previously held beliefs about IBD diagnosis, treatment, and pathogenesis. The bo…
Available Online
View e-Book
Other Authors
Cohen, Russell D
Responsibility
Russell D. Cohen, editor
Edition
Third edition
Place of Publication
Cham
Publisher
Humana Press
Date of Publication
2017
Physical Description
1 online resource (xiii, 366 pages) : 33 illus., 30 illus. in color
Series Title
Clinical gastroenterology
ISBN
9783319537634
9783319537610 (print ed.)
ISSN
2197-7399
Subjects (MeSH)
Inflammatory Bowel Diseases - diagnosis
Inflammatory Bowel Diseases - therapy
Abstract
The latest edition of this text provides a comprehensive overview of the "natural flow of knowledge" regarding inflammatory bowel disease, with an emphasis on state-of-the art approaches that should be the basis for diagnosis and treatment of most patients. In addition to updated chapters, this volume includes new chapters on such topics as the impending biosimilar revolution, quality of care, and new challenges to previously held beliefs about IBD diagnosis, treatment, and pathogenesis. The book is also one of the first to have a chapter written specifically by and for physician extenders in the training of colleagues and the treatment of patients, which is of increasing importance moving forward in the medical profession. Written by experts in the field, Inflammatory Bowel Disease: Diagnosis and Therapeutics, Third Edition is a valuable resource for physicians, nurses, researchers, and other health care providers interested in the latest cutting-edge knowledge for treating patients with inflammatory bowel disease.
Contents
The New Face of IBD -- IBD in the New World, Old World, Your World -- Do Genes Matter? -- State of the Art and Future Predictions: Isn't There a Test for That? Diagnosing IBD -- Not Your Grandma's Colonoscope: Novel Endoscopic Approaches -- Radiology Redefined -- Prevention of Colorectal Cancer in IBD Using Advanced Technologies -- Pathological Diagnosis of IBD -- Tricks of the Trade: Treating Your Patient with Mild to Moderate IBD -- Tricks of the Trade: Treating Your Patient with Moderate to Severe IBD -- IBD Therapies: Coming Attractions -- The Different Drummer: Non-traditional Therapeutic Approaches -- The Biosimilar Revolution : Coming to an IBD Patient Near You? -- Nutrition Matters in IBD -- Size Matters: Special Considerations in The Pediatric IBD Patient -- State of the Art and Future Predictions: "By the way... I'm Pregnant" -- Update on the Surgical Treatment of IBD -- Managing the IBD Patient with Ostomy Complications -- The New Sheriffs in Town: The Role of APNs and PAs in an IBD Practice -- It's Quality, Not Quantity That Matters -- The Economics of IBD.
Format
e-Book
Location
Online
Less detail

Telemanagement of Inflammatory Bowel Disease

https://libcat.nshealth.ca/en/permalink/provcat39871
Raymond K. Cross, Andrew R. Watson, editors. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This volume provides a comprehensive, state-of-the art review of inflammatory bowel disease and its management through the use of telemedicine applications. The book reviews barriers to successful outcomes in patients with IBD and offers a rationale for how self-management and telemedicine approaches can improve care in chronic illnesses such as IBD. This volume also includes a summary of the burden of telephone encounters in patients with IBD, characteristics of frequent callers to the office,…
Available Online
View e-Book
Other Authors
Cross, Raymond K
Watson, Andrew R
Responsibility
Raymond K. Cross, Andrew R. Watson, editors
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xii, 194 p. : 31 illus., 23 illus. in color)
ISBN
9783319222851
9783319222844 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases
Telemedicine - methods
Treatment Outcome
Abstract
This volume provides a comprehensive, state-of-the art review of inflammatory bowel disease and its management through the use of telemedicine applications. The book reviews barriers to successful outcomes in patients with IBD and offers a rationale for how self-management and telemedicine approaches can improve care in chronic illnesses such as IBD. This volume also includes a summary of the burden of telephone encounters in patients with IBD, characteristics of frequent callers to the office, outcomes associated with high telephone use, and strategies to provide education via telephone to patients with IBD. Prior literature on implementation of teleconsultation in research and clinical practice, as well as mobile applications used to track symptoms, quality of life, diet, and medication use in IBD are also explored in the book. Written by experts in the field, Telemanagement of Inflammatory Bowel Disease is a valuable resource for gastroenterologists, surgeons, and other clinicians dealing with, and interested in, this novel adjunct to routine care for inflammatory bowel disease.
Contents
1. Barriers to Successful Outcomes in Patients with Inflammatory Bowel Diseases -- 2. Experience with Telemedicine Systems in Chronic Illness: What Can We Learn -- 3. Telephone Encounters in Inflammatory Bowel Disease (IBD) Care: Burden, Risk Factors, and Opportunities for Intervention -- 4. Teleconsultation in the Care of Patients with IBD -- 5. Self-Management Techniques in IBD -- 6. Mobile Applications for Patients with Inflammatory Bowel Disease -- 7. Telemonitoring and Self-Care in Patients with IBD -- 8. Teleconferences to Facilitate Multidisciplinary Care and Education in IBD -- 9. System Requirements for Delivery of Telemedicine Services -- 10. Legal, Regulatory, and Ethical Issues in the Use of Telemedicine -- 11. Future Directions in Telemedicine Applications for Inflammatory Bowel Disease (IBD).
Format
e-Book
Location
Online
Less detail

Nutritional Management of Inflammatory Bowel Diseases : A Comprehensive Guide

https://libcat.nshealth.ca/en/permalink/provcat40022
Ashwin N. Ananthakrishnan, editor. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is a state-of-the art review for clinicians and dieticians with an interest in nutrition and inflammatory bowel diseases (Crohn's disease, ulcerative colitis). The volume covers new data about dietary risk factors for Crohn's disease and ulcerative colitis, examines the association between diet and microbiome, describes the various diets in the management of these diseases, and discusses macro- and micronutrient deficiency that occurs in such patients. The book also examines the manag…
Available Online
View e-Book
Other Authors
Ananthakrishnan, Ashwin N
Responsibility
Ashwin N. Ananthakrishnan, editor
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xv, 237 p. : 3 illus., 2 illus. in color)
ISBN
9783319268903
9783319268880 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases - diet therapy
Short Bowel Syndrome - diet therapy
Abstract
This book is a state-of-the art review for clinicians and dieticians with an interest in nutrition and inflammatory bowel diseases (Crohn's disease, ulcerative colitis). The volume covers new data about dietary risk factors for Crohn's disease and ulcerative colitis, examines the association between diet and microbiome, describes the various diets in the management of these diseases, and discusses macro- and micronutrient deficiency that occurs in such patients. The book also examines the management of patients on total parenteral nutrition, and management of the short gut syndrome with TPN and novel pharmacologic therapies. Written by experts in their fields, Nutritional Management of Inflammatory Bowel Diseases: A Comprehensive Guide is a valuable and uniquely specialized resource for gastroenterologists, nutritionists, primary care physicians, and other health care providers and researchers dealing with the management of these complex illnesses.
Contents
Part I. Diet and the Pathogenesis of Inflammatory Bowel Diseases -- Diet and Microbiome in Inflammatory Bowel Diseases -- Dietary Risk Factors for the Onset and Relapse of Inflammatory Bowel Disease -- Part II. Nutritional Deficiencies in Inflammatory Bowel Diseases -- Vitamin D and Inflammatory Bowel Diseases -- Diagnosis and Management of Iron Deficiency in Inflammatory Bowel Disease -- Other Micronutrient Deficiencies in Inflammatory Bowel Disease: From A to Zinc -- Part III. Nutritional Treatment of Inflammatory Bowel Diseases -- Enteral Nutrition in the Treatment of Inflammatory Bowel Disease -- Elimination Diets for Inflammatory Bowel Disease -- Prebiotics and Probiotics in Inflammatory Bowel Disease -- Part IV. Complicated Nutritional Issues in Infl ammatory Bowel Diseases -- Total Parenteral Nutrition and Inflammatory Bowel Disease: Indications, Long term Outcomes and Complications -- Short Bowel Syndrome: Physiologic Considerations and Nutritional Management -- Short Bowel Syndrome: Pharmacotherapy -- Small Bowel Transplantation.
Format
e-Book
Location
Online
Less detail

Colitis-Associated Cancer

https://libcat.nshealth.ca/en/permalink/provcat40391
Masato Kusunoki, editor. (1st ed.) --Tokyo: Springer Japan , c2016.
Available Online
View e-Book
Location
Online
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the late…
Available Online
View e-Book
Other Authors
Kusunoki, Masato
Responsibility
Masato Kusunoki, editor
Edition
1st ed.
Place of Publication
Tokyo
Publisher
Springer Japan
Date of Publication
c2016
Physical Description
1 online resource (viii, 150 p. : 21 illus., 15 illus. in color)
ISBN
9784431555223
9784431555216 (print ed.)
Subjects (MeSH)
Colitis - complications
Colonic Neoplasms - etiology
Inflammatory Bowel Diseases
Abstract
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
Contents
1. Colitis-Associated Cancer: Overview -- Part I. Clinical Features -- 2. Incidence and Risk Factors -- 3. Prevention and Prognosis -- Part II. Diagnosis -- 4. Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- 5. Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- 6. Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- 7. Surgical Treatment for Colorectal Cancer in Crohn's Disease.
Format
e-Book
Location
Online
Less detail

Infliximab (Remicade) therapy

https://libcat.nshealth.ca/en/permalink/chpams34944
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1140
Available Online
View Pamphlet
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Subjects (LCSH)
Inflammatory bowel diseases
Infliximab
Abstract
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1140
Less detail

Adalimumab (Humira) therapy

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1207
Available Online
View Pamphlet
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1207
Less detail

5-Aminosalicylate (5-ASA)

https://libcat.nshealth.ca/en/permalink/chpams35397
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Crohn Disease - drug therapy
Colitis - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Colitis
Abstract
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Responsibility
Prepared by: Jennifer Stewart, RN; Gastroenterology
Prepared by: Kaleigh MacIsaac, B.ScPharm; Gastroenterology
Revised by: Phyllis Durning, RN
Revised by: Alison Harding, B.Sc.
Pamphlet Number
1483
Less detail

30 records – page 1 of 2.